Literature DB >> 16794097

Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma.

M Can1, S Demirtas, O Polat, A Yildiz.   

Abstract

BACKGROUND: In the emergency department (ED), the diagnosis of acute myocardial ischaemia is very difficult because of the absence of a rapid, reliable diagnostic test. The albumin cobalt binding (ACB) assay is a good candidate as a marker for for detection of myocardial ischaemia, as it is an easy and rapid test. To date, however, the way in which alterations in metal binding sites of human serum albumin depend on ischaemic events has not been reported in detail.
METHODS: We studied 92 patients admitted to the ED within 1 hour after exposure to trauma. Trauma patients divided into two groups according to their Injury Severity Score (ISS): group 1 comprised mildly injured patients who had ISS trauma score <15 (n = 60), and group 2 comprised moderately injured patients with ISS trauma score >15 (n = 32). The blood specimens of 30 healthy volunteers were studied as a control group.
RESULTS: Group 2 showed significantly increased ACB levels (0.63 (0.18) absorbance units (ABSU)) compared with group 1 (0.54 (0.14) ABSU) (p<0.05) and controls (0.39 (0.05) ABSU) (p<0.01). Group 1 showed significantly enhanced ACB values compared with controls (0.54 (0.14) v 0.39 (0.05) ABSU) (p<0.01).
CONCLUSION: Consequently, trauma enhances ACB levels, which may affect the diagnostic performance of the ACB assay, and this effect can limit the ability of the assay for detection of myocardial ischaemia in patients exposed to trauma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794097      PMCID: PMC2579548          DOI: 10.1136/emj.2005.030486

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  11 in total

1.  Complete amino acid sequence of human serum albumin.

Authors:  B Meloun; L Morávek; V Kostka
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

2.  Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.

Authors:  R H Christenson; S H Duh; W R Sanhai; A H Wu; V Holtman; P Painter; E Branham; F S Apple; M Murakami; D L Morris
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

3.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care.

Authors:  S P Baker; B O'Neill; W Haddon; W B Long
Journal:  J Trauma       Date:  1974-03

4.  The time of onset and severity of acidosis in myocardial ischaemia.

Authors:  S M Cobbe; P A Poole-Wilson
Journal:  J Mol Cell Cardiol       Date:  1980-08       Impact factor: 5.000

5.  Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

Authors:  D Bar-Or; J V Winkler; K Vanbenthuysen; L Harris; E Lau; F W Hetzel
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

6.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

Authors:  D Bar-Or; E Lau; J V Winkler
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

7.  Low albumin level in the emergency department: a potential independent predictor of delayed mortality in blunt trauma.

Authors:  Richard L Yukl; David Bar-Or; Lisbeth Harris; Howard Shapiro; James V Winkler
Journal:  J Emerg Med       Date:  2003-07       Impact factor: 1.484

8.  Site-specific N-terminal auto-degradation of human serum albumin.

Authors:  B Chan; N Dodsworth; J Woodrow; A Tucker; R Harris
Journal:  Eur J Biochem       Date:  1995-01-15

9.  Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction.

Authors:  A H Wu; D L Morris; D R Fletcher; F S Apple; R H Christenson; P C Painter
Journal:  Cardiovasc Toxicol       Date:  2001       Impact factor: 3.231

10.  Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

Authors:  Nadhipuram V Bhagavan; Ernest M Lai; Patricia A Rios; Jinsheng Yang; Anna M Ortega-Lopez; Hiroko Shinoda; Stacey A A Honda; Carlos N Rios; Cheryl E Sugiyama; Chung-Eun Ha
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

View more
  7 in total

1.  Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas.

Authors:  Teresa Stachowicz-Stencel; Anna Synakiewicz; Anna Owczarzak; Aleksandra Sliwińska; Ewa Aleksandrowicz-Wrona; Wiesawa Lysiak-Szydowska; Anna Balcerska
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Study of Ischemia Modified Albumin as a Biomarker in Acute Ischaemic Stroke.

Authors:  Bindu Menon; Krishnana Ramalingam; Vamsi Krishna
Journal:  Ann Neurosci       Date:  2018-06-28

3.  Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma?

Authors:  Hamit Yasar Ellidag; Nurullah Bulbuller; Esin Eren; Sedat Abusoglu; Evren Akgol; Mustafa Cetiner; Necat Yılmaz
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

4.  Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancer.

Authors:  Masaaki Satoh; Kazuhiko Kotani; Alejandro Gugliucci; Hisanaga Horie; Russell Caccavello; Mamoru Takeuchi
Journal:  ScientificWorldJournal       Date:  2014-12-08

5.  The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations.

Authors:  Firat Uygur; Hakan Tanriverdi; Murat Can; Tacettin Ornek; Fatma Erboy; Bulent Altinsoy; Figen Atalay; Murat Damar; Furuzan Kokturk; Meltem Tor
Journal:  Mediators Inflamm       Date:  2016-01-20       Impact factor: 4.711

6.  Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.

Authors:  Yüksel Çavuşoğlu; Şule Korkmaz; Selda Demirtaş; Erkan Gencer; Hatice Şaşmaz; Fezan Mutlu; Hakan Güneş; Uğur Kadir Mert; Sedat Özdemir; Süleyman Kalaycı; Mehmet Birhan Yılmaz
Journal:  Anatol J Cardiol       Date:  2015-08       Impact factor: 1.596

Review 7.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.

Authors:  James P C Coverdale; Kondwani G H Katundu; Amélie I S Sobczak; Swati Arya; Claudia A Blindauer; Alan J Stewart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-20       Impact factor: 4.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.